Ultrasound contrast media and their use in obstetrics and gynecology

Ultrasound in Medicine and Biology

Volumn 23, Issue 9, 1997, Pages 1287-1298

  Abramowicz, Jacques S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bioeffects; Gynecology; Obstetrics; Ultrasound contrast agents

Indexed keywords

COLOR IMAGE PROCESSING; DOPPLER EFFECT; GYNECOLOGY; IMAGE ENHANCEMENT; MEDICAL IMAGING; OBSTETRICS; ONCOLOGY; ULTRASONIC IMAGING;

BIOEFFECTS;

CONTRAST MEDIA;

CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; GYNECOLOGY; IMAGE ANALYSIS; OBSTETRICS; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SAFETY; VASCULARIZATION;

CONTRAST MEDIA; FEMALE; GENITAL DISEASES, FEMALE; GENITALIA, FEMALE; GYNECOLOGY; HUMANS; IMAGE ENHANCEMENT; OBSTETRICS; PLACENTA; PREGNANCY; SAFETY; ULTRASONOGRAPHY, PRENATAL;

EID: 0030662309     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(97)00201-9     Document Type: Review

References (202)

1. Abramowicz JS, Miller RR, Parker KJ, Violante M, Levene H. Sonographic imaging of the perfused human placenta with contrast media. Ultrasound Contrast Research Symposium, San Diego, 1997.
2. Abramowicz JS, Phillips DB, Jessee LN, Levene H, Parker KB, Miller RK. Enhanced blood flow visualization in the perfused human placenta by Albunex, an ultrasound contrast medium. Placenta 1996;17:A.21.
3. Achiron R, Lipitz S, Sivan E, Goldenberg M, Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 1995;14:685-658.
4. Allahbadia GN. Fallopian tubes and ultrasonography: The Sion experience. Fertil Steril 1992;58:901-907.
5. Andre MP, Steinbach G, Mattrey RF. Enhancement of the echogenicity of flowing blood by the contrast agent perflubron. Invest Radiol 1993;28:502-506.
6. Angeli E, Carpanelli R, Crespi G, Zanello A, Sironi S, Del Maschio A. Efficacy of SHU508A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization. Radiol Medica 1994; 87(Suppl 1):24-31.
7. Aronson S, Walker R, Wiencek JG, Zaroff JG, Feinstein SB, Zachary L. Evaluation of changes in skeletal muscle blood flow in the dog with contrast ultrasonography. Plastic Reconst Surg 1995;95:114-118.
8. Aronson S, Wiencek JG, Feinstein SB, Heidenreich PA, Zaroff JG, Walker R, Roizen MF. Assessment of renal blood flow with contrast ultrasonography. Anesth Analg 1993;76:964-970.
9. Atala A, Wible JH, Share JC, Carr MC, Retik A, Mandell J. Sonography with sonicated albumin in the detection of vesicoureteral reflux. J Urol 1993;150:756-758.
10. Ayida G, Harris P, Kennedy S, Seif M, Barlow D, Chamberlain P. Hysterosalpingo-contrast-sonography (HyCoSy) using Echovist®-200 in the outpatient investigation of infertility patients. Br J Radiol 1996a;69:910-3.
11. Ayida G, Kennedy S, Barlow D, Chamberlain P. Contrast sonography for uterine cavity assessment: a comparison of conventional two-dimensional with three-dimensional transvaginal ultrasound; a pilot study. Fertil Steril 1996b;66:848-850.
12. Baggs R, Penney DP, Cox C, Child SZ, Raeman CH, Dalecki D, Carstensen EL. Thesholds for ultrasonically induced lung hemorrhage in neonatal swine. Ultrasound Med Biol 1996;22:119-128.
13. Balen FG, Allen CM, Lees WR. Ultrasound contrast agents. Clin Radiol 1994;49:77-82.
14. Balen FG, Allen CM, Siddle NC, Lees WR. Ultrasound contrast hysterosalpingography-evaluation as an outpatient procedure. Br J Radiol 1993;66:592-599.
15. Barnhart JL, Harada M, Lyle LR, Saravis CA. Immunological reactions of human recipients to repeated exposures to Albunex microspheres. Invest Radiol 1991;26:S192-S193.
16. Berwing K, Schlepper M. Echocardiographic imaging of the left ventricle by peripheral intravenous injection of echocontrast agent. Am Heart J 1988;115:399-408.
17. Bleeker HJ, Shung KK, Barnhart J. On the application of ultrasonic contrast agent for blood flowmetry and assessment of cardiac perfusion. J Ultrasound Med 1990;9:461-471.
18. Blomley M, Cosgrove M. Contrast agents in ultrasound. Br J Hosp Med 1995;55:6-7.
19. Bogdahn U, Frohlich T, Becker G, Krone A, Schlief R, Schurmann J, Jachimczak P, Hofmann E, Roggendorf W, Roosen K. Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography. Radiology 1994;192:141-148.
20. Bonilla-Musoles F, Simon C, Serra V, Sampaio M, Pellicer A. An assessment of hysterosalpingosonography (HSSG) as a diagnostic tool for uterine cavity defects and tubal patency. J Clin Ultrasound 1992;20:175-181.
21. Bourne TH, Campbell S, Steer CV, Royston P, Whitehead MI, Collins WP. Detection of endometrial cancer by transvaginal ultrasonography with colour flow imaging and blood flow analysis: a preliminary report. Gyn Oncol 1991;40:253-259.
22. Brayman AA, Azadniv M, Cox C, Miller MW. Hemolysis of albunex-supplemented, 40% hematocrit human erthrocytes in vitro by 1-MHz pulsed ultrasound: acoustic pressure and pulse length dependence. Ultrasound Med Biol 1996;22:927-938.
23. Burns PN. Ultrasound contrast agents in radiological diagnosis. Radiol Medica 1994;87(Suppl. 1):71-82.
24. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51(Suppl. 1):50-55.
25. Caiati C, Aragona P, Iliceto S, Rizzon P. Improved Doppler detection of proximal left anterior descending coronary artery stenosis after intravenous injection of a lung-crossing contrast agent: a transesophageal Doppler echocardiographic study. J Am Coll Cardiol 1996;27:1413-1421.
26. Campani R, Bozzini A, Calliada F, Bottinelli O, Anguissola R, Conti MP, Corsi G. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SHU508A (Levovist) Schering. Radiol Medica 1994;87(Suppl. 1):32-40.
27. Campbell S, Bourne TH, Tan SL. Hysterosalpingo contrast sonography (HyCoSy) and its future role within the investigation of infertility in Europe. Ultrasound Obstet Gynecol 1994;4:245-253.
28. Carroll BA, Turner RJ, Tickner EG, Boyle DB, Young SW. Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. Invest Radiol 1980;15:260-266.
29. Cennamo G, Rosa N, Vallone GF, Smaltino F. First experience with a new echographic contrast agent. Br J Ophthal 1994;78:823-826.
30. Chadduck WM. Perioperative sonography (review). J Child Neurol 1989;4:S91-S100.
31. Christiansen C, Vebner AJ, Muan B, Vik H, Haider T, Nicolaysen H, Skotland T. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres. Int Arch Allergy Immunol 1994;104:372-378.
32. Church C. The effects of an elastic solid surface layer on the radial pulsations of gas bubbles. J Acoust Soc Am 1995;97:1510-1521.
33. Cicinelli E, Romano F, Anastasio PS, Blasi N, Parisi C. Sonohysterography versus hysteroscopy in the diagnosis of endouterine polyps. Gynecol Obstet Invest 1994;38:266-271.
34. Cicinelli E, Romano F, Anastasio PS, Blasi N, Parisi C, Galantino P. Transabdominal sonohysterography, transvaginal sonography and hysteroscopy in the evaluation of submucous myomas. Obstet Gynecol 1995;85:42-47.
35. Cohen I, Altaras MM, Shapira J, Tepper R, Beyth Y. Postmenopausal tamoxifen treatment and endometrial pathology. Obstet Gynecol Surv 1994;49:823-829.
36. Cohen I, Rosen DJ, Tepper R, Cordoba M, Shapira Y, Altaras MM, Yigael D, Beyth Y. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993;12:275-280.
37. Coley BD, Frush DP, Babcock DS, O'Hara SM, Lewis AG, Gelfand MJ, Bove KE, Sheldon CA. Acute testicular torsion: comparison of unenhanced and contrast-enhanced power Doppler ultrasound, color Doppler ultrasound and radionuclide imaging. Radiology 1996;199:441-446.
38. Coley BD, Trambert MA, Mattrey RF. Perfluorocarbon enhanced sonography: value in detecting acute venous thrombosis in rabbits. Am J Roentgen 1994;163:961-4.
39. Correas J, Helenon O, Mejean A, Legendre C, Pourcelot L, Moreau J. Value of US with Dodecafluoropentane in the diagnosis of renal diseases: preliminary results (Abst). Radiology 1996;201:266.
40. Cosgrove D. Why do we need contrast agents for ultrasound? Clin Radiol 1996a;51(Suppl. 1):1-4.
41. Cosgrove D. Ultrasound contrast enhancement of tumours. Clin Radiol 1996b;51(Suppl. 1):44-49.
42. Crequat J, Pennehouat G, Cornier E, Naouri M, Thebault Y, Madelenat P. Evaluation of intrauterine pathology and tubal patency by contrast echography. Contraception Fertil Sexual 1993;21:861-844.
43. Crvenkovic G, Karlan BY, Platt LD. Current role of ultrasound in ovarian cancer screening. Clin Obstet Gynecol 1996;39:259-267.
44. Cullinan JA, Fleisher AC, Kepple DM, Arnold AL. Sonohysterography: a technique for endometrial evaluation. Radiographics 1995; 15:501-514.
45. D'Arrigo J, Simon RH, Ho SY. Lipid coated uniform microbubble for earlier sonographic detection of brain tumors. J Neuroimag 1991; 1:134-139.
46. Davidson GB, Leeton J. A case of infertility investigated by contrast-enhanced echo-gynecology. J Clin Ultrasound 1988;16:44-47.
47. Daw E. Amniography and fetography: old diagnostic aids-new uses. Clin Exp Obstet Gynecol 1986;13:10-11.
48. de Jong N, Ten Gate FJ. New ultrasound contrast agents and technological innovations. Ultrasonics 1996;34:587-590.
49. de Jong N, Ten Cate FJ, Lancee CT, Roelandt JR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991;29:324-330.
50. Degenhardt E, Jibril S, Gohde M, Eisenhauer B, Schlosser HW. Ambulatory contrast hysterosonography as a possibility for assessing tubal patency. Geburtshilfe Frauenheilkd 1995;55:143-149.
51. Deichert V, Schlief R, van de Sandt M, et al. Transvaginal hystero-contrast-sonography (Hy-Co-Sy) compared with conventional tubal diagnosis. Hum Reprod 1989;4:418-424.
52. Deichert V, van de Sandt M, Lauth G, Daume E. Transvaginal hysterosonography. A new diagnostic procedure for differentiating intrauterine and myometrial findings. Geburstshilfe Frauenheilkd 1988;48:835-844.
53. Denbow ML, Blomley MJK, Cosgrove DO, Fisk NM. Ultrasound microbubble contrast angiography in monochorionic twin fetuses. Lancet 1997;349:773.
54. Deng CX, Xu Q, Apfel RE, Holland CK. Inertial cavitation produced by pulsed ultrasound in controlled host media. J Acoust Soc Am 1996;100:1199-1208.
55. Derchi LE, Rizzatto G, Solbiati L. Contrast media in echography. Radiol Medica 1992;84:208-215.
56. Duda VF, Rode G, Schlief R. Echocontrast agent enhanced color flow imaging of the breast. Ultrasound Obstet Gynecol 1993;3:191-194.
57. Elewaut AE, Afschrift M. Hydrocolonic sonography: novel screening method for the detection of colonic disease? Bilgebund 1995;62: 230-234.
58. Ernst H, Hahn EG, Balzer T, Schlief R, Heyder N. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist®. J Clin Ultrasound 1996;24:31-35.
59. Fan P, Czuwala PJ, Nanda NC, Rosenthal SM, Yoganathan A. Comparison of various agents in contrast enhancement of color Doppler flow image: an in vitro study. Ultrasound Med Biol 1993;19:45-47.
60. Feichtinger W. Transvaginal three-dimensional imaging. Ultrasound Obstet Gynecol 1993;3:375-378.
61. Feigenbaum H, Stone JM, Lee DA, Nasser WK, Chang S. Identification of ultrasound echoes from the left ventricle by use of intracardiac injections of indocyanine green. Circulation 1970;41:615-621.
62. Fernandez JM, Vaño E, Guibelalde E. Patient doses in hysterosalpingography. Br J Radiol 1996;69:751-754.
63. Fleischer AC, Rodgers WH, Rao BK. Assessment of ovarian tumor vascularity with transvaginal color ultrasonography. J Ultrasound Med 1990;10:563-568.
64. Fobbe F, Ohnesorge I, Reichel M, Dollinger P, Schurmann R, Wolf KJ. Color-coded duplex sonography and ultrasound contrast medium in the study of peripheral arteries-initial clinical experiences. Ultraschall Med 1992a;13:193-198.
65. Fobbe F, Siegert J, Fritzsch T, Wolf KJ. Extended diagnosis of color-coded duplex sonography by ultrasound contrast media. Imaging of movement of the urinary tract and tubes in animal experiment. Ultraschall Med 1992b;13:31-36.
66. Forsberg F, Liu JB, Merton DA, Rawool NM, Goldberg BB. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995;14:949-957.
67. Fritzsch T, Schartl M, Siegert J. Preclinical and clinical results with an ultrasonic contrast agent. Invest Radiol 1988;23:S302-S305.
68. Fuciarelli AF, Sisk EC, Thomas RM, Miller DL. Induction of base damage in DNA solutions by ultrasonic cavitation. Free Rad Biol Med 1995;18:231-238.
69. Fujita Y, Yura T, Fujioka H, Uchida K, Shoji T, Takahashi N, Sumikura T, Yuasa S, Matsuo H. Assessment of the distribution of renal cortical blood flow by contrast ultrasonography. Jpn J Nephrol 1994;36:218-226.
70. Fujiwaki S, Saito J, Horikoshi H, Haginiwa I, Ishizuka B, Amemiya A, Iida T, Hayashi K, Sakuyama K, Shinagawa T. Diagnosis of intrauterine disorders by sonohysterography. Acta Obstet Gynecol Jpn 1995;47:437-440.
71. Gao Y, Gao Y, Yang H. Effects of diagnostic ultrasound on villus ultrastructure of early pregnancy. Chin J Obstet Gynecol 1996;31: 156-158.
72. 2 injection in staging hepatocellular carcinomas. Radiol Med 1994;87(Suppl 1):65-70.
73. Gaucherand P, Piacenza JM, Salle B, Rudigoz RC. Sonohysterography of the uterine cavity: preliminary investigations. J Clin Ultrasound 1995;23:339-348.
74. Ge J, Erbel R. Novel techniques of coronary artery imaging. Curr Op Cardiol 1995;10:626-633.
75. Geny B, Mettauer B, Muan B, Bischoff P, Epailly E, Piquard F, Eisenmann B, Haberey P. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol 1993;22:1193-1198.
76. Gillam LD, Kaul S, Fallon JT, Levine RA, Hedley-Whyte ET, Guerrero JL, Weyman AE. Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain and kidney. J Am Coll Cardiol 1984;6:687-694.
77. Goldberg BB. Ultrasonic cholangiography, gray-scale B-scan evaluation of the common bile duct. Radiology 1976;118:401-404.
78. Goldberg BB, Hilpert PL, Burns PM, Liu JB, Newman LM, Merton DA, Witlin LA. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990;177: 713-717.
79. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994;20:319-333.
80. Goldstein S. Incorporating endovaginal ultrasonography into the overall gynecologic examination. Am J Obstet Gynecol 1990;162:625-632.
81. Goldstein SR. Use of ultrasonohysterography for triage of perimenopausal patients with unexplained uterine bleeding. Am J Obstet Gynecol 1994;170:565-70.
82. Goldstein SR. Saline infusion sonohysterography. Clin Obstet Gynecol 1996;39:248-258.
83. Gramiak R, Shah PM. Echocardiogram of the aortic root. Invest Radiol 1968;3:356-366.
84. Grandberg S, Wikland M, Karlsson B, Norström A, Friberg LG. Endometrial thickness as measured by endovaginal ultrasound for identifying endometrial abnormality. Am J Obstet Gynecol 1991; 164:47-52.
85. Gücer F, Haüsler MCH, Arikan MG, Peiben D. Contrast sonography for inconclusive findings on routine sonography. Int J Obstet Gynecol 1996;54:161-165.
86. Guerriero S, Ajossa S, Mais V, Paoletti AM, Melis GB. The screening of tubal abnormalities in the infertile couple. J Assoc Reprod Gen 1996;13:407-412.
87. Haeusler MC, Ryan G, Robson SC, Lipitz S, Rodeck CH. The use of saline solution as a contrast medium in suspected diaphragmatic hernia and renal agenesis. Am J Obstet Gynecol 1993;168:1486-1492.
88. Harada M, Ando H, Kato M, Yoshida S, Harada M, Kondo I, Suganuma N, Tomoda Y. Transvaginal hysterosonography in the evaluation of uterine abnormalities in infertile women. Ultrasound Obstet Gynecol 1996;8(Suppl 1):59.
89. Hausmann D, Sudhir K, Mullen WL, Fitzgerald PJ, Ports TA, Daniel WG, Yock PG. Contrast-enhanced intravascular ultrasound: validation of a new technique for delineation of the vessel wall boundary. J Am Coll Cardiol 1994;23:981-987.
90. Hawe W, Milz P. The clinical value of air sonography in the diagnosis of meniscus lesions. A prospective study of 50 knee joints. Sportverletz Sportschaden 1991;5:119-126.
91. Hellebust H, Christiansen C, Skotland T. Biochemical characterization of air-filled albumin microspheres. Biotech Appl Biochem 1993; 18:227-237.
92. Hill CR, Ter Haar GR. High intensity focused ultrasound-potential for cancer treatment. Br J Radiol 1995;68:1296-1303.
93. Hoff L, Christiansen C, Skotland T. Consideration about the contribution of acoustic backscatter from Albunex microspheres with different sizes. J Ultrasound Med 1994;13:181-182.
94. Holte J, Rasmussen C, Morris H. First clinical experience with sonicated human serum albumin (Albunex) as an intrafallopian ultrasound contrast medium. Ultrasound Obstet Gynecol 1995;6:62-65.
95. Hösli IM, Tercanli S, Surbek DV, Almendral A, Holzgreve W. Comparison between HSG and hysterosalpingo-contrast-sonography (HyCoSy) for fallopian tubal patency. Ultrasound Obstet Gynecol 1996;8(Suppl 1):78.
96. Jaspers V, Quakernack K. Intrauterine sonography and transvaginal colour Doppler sonography with contrast agent for the diagnosis of cervical carcinoma. Ultrasound Obstet Gynecol 1996;8(Suppl. 1): 112.
97. Jauniaux E, Jurkovic D, Campbell S, Hustin J. Doppler ultrasonographic features of the developing placental circulation: correlation with anatomic findings. Am J Obstet Gynecol 1992;166:585-587.
98. Jeffers RJ, Feng RQ, Fowlkes JB, Hunt JW, Kessel D, Cain CA. Dimethyl formamide as an enhanced cavitation-induced cell-lysis in vitro. J Acoust Soc Am 1995;97:669-676.
99. Kaneko K, Kuwatsuru R, Fukuda Y, Yamataka A, Yabuta K, Katayama H, Miyano T. Contrast sonography for detection of vesicoureteral reflux. Lancet 1994;344:687.
100. Kedar RP, Cosgrove D, McCready VR, Bamber JC. Microbubble Doppler angiography of breast masses - work in progress with Levovist®. Radiology 1995;197:39-43.
101. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996;198:679-686.
102. Keller MW, Feinstein SB, Watson DD. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. Am Heart J 1987;114: 570-575.
103. Keller MW, Glasheen ME, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiography 1989;2:48-52.
104. Kremkau FW, Gramiak R, Carstensen EL, Shah PM, Kramer DH. Ultrasonic detection of cavitation at catheter tips. Am J Roentgen 1970;110:177-183.
105. Kurjak A, Zalud I, Alfirevic Z, Jurkovic D. The assessment of abnormal pelvic flow by transvaginal color and pulsed Doppler. Ultrasound Med Biol 1990;16:437-442.
106. Lafortune M, Burns PN, Patriquin HB. Tissue characterization with echography and Doppler. Radiol Medica 1993;85:538-543.
107. Leen E, McArdle CS. Ultrasound contrast agents in liver imaging. Clin Radiol 1996;51(Suppl. 1):35-39.
108. Leen E, Angerson HW, Warren P, O'Gorman P, Moule B, Carter EC, McArdle CS. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastasis using galactose microparticles: a preliminary report. Br J Surg 1994;81:252-254.
109. Lerner J, Bohm Velez M, Cullinan J, Janik G, Koh C, Parsons A, Sanders R, Serafini P, Session D, Yee B, Rabin D, Gottesfeld R. Evaluation of tubal patency by contrast enhanced sonohysterosalpingography. Ultrasound Obstet Gynecol 1996;8(Suppl. 1):130.
110. Limberg B. Diagnosis of colonic tumors and chronic inflammatory colonic diseases by hydrocolonic sonography. Radiologe 1993;33: 407-411.
111. Luo LL. Ultrasonic study with hydrotubation of tubal patency. Chin J Obstet Gynecol 1990;25:149-151.
112. Madjar H, Prompeler H, Schurmann R, Goppinger A, Brechwoldt M, Pfleiderer A. Improving diagnosis of blood supply of breast tumors by echo-contrast media. Geburtshilfe Frauenheil 1993;53:866-869.
113. Magnin P, Thoulon JM. Amniography (fetography) with liposoluble contrast media. Iconography. Bull Fed Soc Gynecol Obstet Langue Franç 1971;23:480-482.
114. Maia H Jr, Barbosa IC, Farias JP, Ladipo OA, Coutinho EM. Evaluation of the endometrial cavity during menopause. Int J Gyn Obstet 1996;52:61-66.
115. Makin IR, Everbach EC, Porter R, Xie F, Meltzer RS. Comparison of cavitational activity of echocontrast agents filled with different gases. Circulation 1995;92(Suppl 1):192.
116. Mardini MK, Lazarte R, Huntington D, Hilliard J, Kramer L, O'Connell R, Allen R, Hephner SI, Ziai M. Diagnosis of cerebral arteriovenous malformation by contrast two-dimensional and Doppler ultrasonography of the head after saline injection in the umbilical arterial line. Am Heart J 1987;114:450-454.
117. Maroulis GB, Parsons AK, Yeko TR. Hydrogynecography: A new technique enables vaginal sonography to visualize pelvic adhesions and other pelvic structures. Fertil Steril 1992;58:1073-1075.
118. Mattrey RF. Perfluoroocytylbromide: a new contrast agent for CT, sonography, and MR imaging. Am J Roentgen 1989;152:247-252.
119. Mattrey RF, Mitten R, Peterson R, Long CD. Vascular ultrasonic enhancement of tissue with perfluorocytlbromide for renal tumor detection. Radiology 1987a;165(Suppl. 1):75-82.
120. Mattrey RF, Scheible FW, Gosink BB, Leopold GR, Long DM, Higgins CB. Perfluorocotylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982;145:759-762.
121. Mattrey RF, Strich G, Shelton RE, Gosink BB, Leopold GR, Lee T, Forsythe J. Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenomegaly: preliminary clinical results. Radiology 1987b;163:339-343.
122. Meltzer RS. Myocardial perfusion imaging by contrast echocardiography: where are we going? J Am Coll Cardiol 1985;6:621-622.
123. Meltzer RS, Tickner G, Sahines TP, Popp RL. The source of the ultrasound contrast effect. J Clin Ultrasound 1980;8:121-127.
124. Meltzer RS, Vermeulen HWJ, Valk NK, Verdouw PD, Lancee CT, Roelandt J. New echocardiographic contrast agents: transmission through the lungs and myocardial perfusion imaging. Cardiovasc Ultrasonography 1982;1:277-282.
125. Mennuti MT, Moranz JG, Schwarz RH, Mellman WJ. Amniography for the early detection for neural tube defects. Obstet Gynecol 1977;49:25-30.
126. Miller DL, Thomas RM. Ultrasound contrast agents nucleate inertial cavitation in vitro. Ultrasound Med Biol 1995;21:1059-1065.
127. Miller RK, Wier PJ, Maulik D, di Sant' Agnese PA. Human placenta in vitro: characterization during 12 hours of dual perfusion. Contrib Gynecol Obstet 1985;13:77-84.
128. Missouris GC, Allen CM, Balen FG, Buckingham T, Lees WR, MacGregor GA. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens 1996;14:519-524.
129. Miszalok V, Fritzsch T, Wollensak J. Contrast echography of the eye and orbit. Ophthalamologica 1986;193:231-235.
130. Mitri FF, Andronikov AD, Perpinyal S, Hofmeyer GJ, Sonnendecker EWW. A clinical comparison of sonographic hydrotubation and hysterosalpingography. Br J Obstet Gynaecol 1991;98:1031-1036.
131. Mulvagh SL, Foley DA, Aeschbacher BC, Klarich KK, Seward JB. Second harmonic imaging of an intravenously administered echo-cardiographic contrast agent. Visualization of coronary arteries and measurement of coronary blood flow. J Am Coll Cardiol 1996;27: 1519-1525.
132. Nanda NC. Echocontrast enhancers: how safe are they? In: Nanda NC, Schlief R (eds); Advances in echo imaging using contrast enhancement, vol. 2. Kluwer Academic Publishers, Dordrecht, The Netherlands 1993:97-110.
133. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319-33.
134. Ophir J, Gobuty A, McWhirt RE, Maklad NF. Ultrasonic backscatter from contrast producing collagen microspheres. Ultrason Imaging 1980;2:67-77.
135. Ophir J, McWhirt RE, Maklad NF. Aqueous solutions as potential ultrasonic contrast agents. Ultrason Imaging 1979;1:265-279.
136. Orr NM, Taylor KJ. Doppler detection of tumor vascularity. In: Taylor KJW, Strandness DE, eds. Clinics in diagnostic ultrasound. Duplex Doppler Ultrasound Vol. 26., New York, Edinburgh, London, Melbourne: Churchill Livingstone, 1990:149-163.
137. Østensen J, Hede R, Myreng Y, Ege T, Holtz E. Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs but not in monkeys or rabbits. Acta Physiol Scand 1992;144:307-315.
138. Panigel M, Abramowicz JS, Miller RK. Techniques: Biophysical methods for assessment of placental function. In: Rama Sastry BV, ed: Placental Pharmacology. New York: CRC Press, Inc. 1996:1-21.
139. Parker KJ, Baggs RB, Lerner RM, Tuthill TA, Violante MR. Ultrasound contrast for hepatic tumors using IDE particles. Invest Radiol 1990;25:1135-1139.
140. Parker KJ, Tuthill TA, Lerner RM, Violante MR. A particular contrast agent with potential for ultrasound imaging of liver. Ultrasound Med Biol 1987;13:555-566.
141. Parsons AK, Cullinan JA, Goldstein SR, Fleisher AC. Sonohysterography, sonosalpingography, and sonohysterosalpingography. A text-atlas of normal and abnormal findings. In: Fleisher AC, Manning FA, Jeanty P, Romero R, eds. Sonography in obstetrics and gynecology, principles and practice. Stamford, CT: Appleton and Lange. 1996:931-967.
142. Parsons AK, Lense JJ. Sonohysterography for endometrial abnormalities: preliminary results. J Clin Ultrasound 1993;21:87-95.
143. Pearce JM, Frisk NM, Rodeck CH. Operative management of abnormalities of amniotic fluid volume. In: Chervenak FA, Isaacson GC, Campbell S, eds: Ultrasound in obstetrics and gynecology. Boston/ Toronto/London: Little Brown Company 1993:1357-1360.
144. Perlitz U, Eliyahu S, Romano S, Weiner E, Zohar N, Lahav D, Shalev E. Relative accuracy of transvaginal sonohysterography and transvaginal sonography in the diagnosis of endometrial polyps and submucous myomas: hysteroscopic biopsy for validation in 61 patients. Ultrasound Obstet Gynecol 1996;8(Suppl. 1):106.
145. Peters AJ, Coulam CB. Hysterosalpingography with color Doppler ultrasonography. Am J Obstet Gynecol 1991;164:1530-1534.
146. Peterson PG, Keifer WS Jr. Diagnosis of an incompetent internal cervical os. Trans Pacific Coast Obstet Gynecol Soc 1972;40:43-49.
147. Porter TR, Xie F, Kricsfeld A. The mechanism and clinical implication of improved left ventricular videointensity following intravenous injection of multi-fold dilutions of albumin with dextrose. Int J Cardiac Imaging 1995;11:117-125.
148. Pourcelot L, Lethiecq M, Patat F, Roncin A, Tranquart F, Berson M. Ultrasound: present and future. Technol Health Care 1996;4:31-36.
149. Rao SB, Slovis TL, Cradock TV, Shah T. Visualization of the intestinal tract by amniography in a fetus with esophageal atresia. Pediatr Radiol 1978;7:241-242.
150. Reisner SA, Shapiro JR, Schwarz KQ, Meltzer RS. Sonication of echo-contrast agents: a standardized and reproducible method. J Cardiovasc Ultrasound 1988;7:273-276.
151. Richman TS, Viscomi GN, DeCherney A, Polan ML, Alcebo LO. Fallopian tubal patency assessed by ultrasound following fluid injection. Radiology 1984;152:507-510.
152. Richter GM, Dux M, Roeren T, Heuschen U, Kauffmann GW. Gastrointestinal diagnosis with hydrosonography and hydro-CT. I: Stomach carcinoma. RöFo 1996;164:281-289.
153. Rigauts H, Casselman J, Steyaert L, Devlies F, Pattyn G. Contribution of MRI and color Doppler sonography in breast cancer diagnosis. J Bel Radiol 1993;76:226-231.
154. Rizaev MN, Azatjan TS, Agejeva TP, Kazylov AA. Contrast echography of uterine tumors using albumin-carbon dioxide foam. Radiol Diagn 1990;31:81-85.
155. Rodeck CH, Mibashan RS, Abramowicz JS, Campbell S. Selective feticide of the affected twin by fetoscopic air embolism. Prenat Diag 1982;2:189-194.
156. Rudigoz RC, Salle B, Sergeant P, Gaucherand P. Results of hysterosonography with saline solution in study of uterine cavity. Ultrasound Obstet Gynecol 1996;8(Suppl 1):94.
157. Santoso T, Roelandt J, Mansyoer H, Abdurahman N, Meltzer RS, Hugenholtz PG. Myocardial perfusion imaging in humans by contrast echocardiography using polygelin colloid solution. J Am Coll Cardiol 1985;6:612-620.
158. Scatamacchia SA, Raptopoulos V, Davidson RI. Saline microbubbles monitoring sonography-assisted abscess drainage. Invest Radiol 1987;22:868-870.
159. Schaer GN, Koechli OR, Schuessler B, Haller U. Improvement of perineal sonographic bladder neck imaging with ultrasound contrast medium. Obstet Gynecol 1995;86:950-954.
160. Schaer GN, Koechli OR, Schuessler B, Haller U. Usefulness of ultrasound contrast medium in perineal sonography for visualization of bladder neck funneling - first observations. Urol 1996;47:452-453.
161. Schlief R. Ultrasound contrast agents. Curr Op Radiol 1991;3:198-207.
162. Schlief R. Diagnostic potential of intravenous contrast enhancement in various areas of cardiovascular Doppler ultrasound: efficacy of a multinational clinical trial with the glactose based agent SH508A. Echocardiography 1993;10:665-682.
163. Schlief R, Bauer A. Ultrasound contrast agents. A new perspective in ultrasound diagnosis. Radiologe 1996;36:51-60.
164. Schlief R, Schurmann A, Neindorf HP. Basic properties and results of clinical trials of ultrasound contrast agents based on glactose. Ann Acad Med Singapore 1993;22:762-767.
165. Schneider K, Jablonski C, Fendel H. Contrast sonography of the urinary tract in children. Ultraschall Med 1986;7:30-33.
166. Schurmann R, Schlief R. Saccharide-based contrast agents. Characteristics and diagnosis potential. Radiol Medica 1994;87(Suppl. 1): 15-23.
167. Schwarz KQ, Bezante GP, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. Efficacy of SHU508A (Levovist) as blood pool enhancer in the Doppler evaluation of multiple vascular regions. Radiol Medica 1994;87(S1):3-14.
168. Sen C, Çepni I, Erel T, Seysioǧlu H, Idil M. Tubal patency by color Doppler hysterosalpingography. Ultrasound Obstet Gynecol 1996; 8(Suppl. 1):105.
169. Shwayder JM. Sonohysterography: an alternative to office hysteroscopy. Ultrasound Obstet Gynecol 1996;8(Suppl. 1):124.
170. Shubik P. Vascularization of tumors: A review. J Cancer Res Clin Oncol 1982;103:211-22.
171. Simpson NAB, Nimrod C, De Vermette R, Fournier J. Determination of intervillous flow in early pregnancy. Placenta 1997;18:287-293.
172. Sohn C, Meyberg G. Initial experience with a new color technique: ultrasound angiography. Zentralblatt Gynakol 1995;117:90-96.
173. Spreafico C, Lanocita R, Frigerio LF, DiTolla G, Garbagnati F, Milella M, Marchiano A, Piragine G, Damascelli B. The Italian experience with SHU508A (Levovist) in breast disease. Radiol Medica 1994; 87(Suppl. 1):59-64.
174. Suren A, Osmers R, Kulenkampff D, Kuhn W. Visualization of blood flow in small ovarian tumor vessel by transvaginal color Doppler sonography after echo enhancement with injection of Levovist. Gynecol Obstet Invest 1994;38:210-212.
175. Suzin J, Respondek A. Use of contrast ultrasonography in the diagnosis of uterovesical fistula. Pol Rev Radiol 1987;51:146-148.
176. Suzumori K, Yagami Y. Diagnosis of human fetal abnormalities by fetography. Teratology 1975;12:303-309.
177. Tachibana K, Tachibana S. Albumin microbubble echo contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995;92:1148-1150.
178. Taylor KJW, Ramos I, Carter D, Morse SS, Snower D, Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 1988;166:57-62.
179. Tei C, Kondo S, Meerbaum S, Ong K, Maurer G, Wood F, Sakamaki T, Shimoura K, Corday E, Shah PM. Correlation of myocardial echo contrast disappearance rate ("washout") and severity of experimental coronary stenosis. J Am Coll Cardiol 1984;3:39-46.
180. Tekay A, Heikkinem H, Martikainen H, Jouppila P. Reliability of transvaginal salpingosonography assessment of tubal patency. Ultrasound Obstet Gynecol 1996;8(Suppl. 1):173.
181. Thomas JD. Contrast ultrasound for assessment of myocardial perfusion: promise and pitfalls. Dev Cardiovasc Med 1995;171:101-109.
182. Toth M, Chervenak F, Ledger WJ, Witkin SS. Hysterosalpyngo-contrast-sonography (HyCoSy) in the follow-up and management of salpyngitis [sic] (PID) patients sensitized to the chlamydia heat shock protein (HSP). Ultrasound Obstet Gynecol 1996;8(Suppl. 1):75.
183. Timor-Tritsch IE, Bar-Yam Y, Elgali S, Rottem S. The technique of transvaginal sonography with the use of a 6.5 MHz probe. Am J Obstet Gynecol 1988;158:1019-1024.
184. Tufecki EC, Girit S, Bayirli E. Evaluation of tubal patency by transvaginal sonosalpingography. Fertil Steril 1992;57:336-340.
185. Unger EC, Lund PJ, Shen DK, Fritz TA, Yellowhair D, New TE. Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. Radiology 1992;185:453-456.
186. Valdez-Cruz LM, Sahn DJ. Ultrasonic contrast studies for the detection of cardiac shunts. J Am Coll Cardiol 1984;3:978-985.
187. Valentin L, Sladkevicius P, Laurini R, Söderberg H, Marsal K. Uteroplacental and luteal circulation in normal first trimester pregnancies: Doppler ultrasonographic and morphologic study. Am J Obstet Gynecol 1996;174:768-775.
188. Van Roessel J, Wamsteker K, Exalto N. Sonographic investigation of the uterus during artificial uterine cavity distention. J Clin Ultrasound 1987;15:439-450.
189. Vandendael A, Debois P, van den Bosch T. Sonohysterography in the detection of endometrial pathology. South Afr Med J 1995;85: 1197.
190. Venezia R, Zangara C. Echohysterosalpingography: new diagnostic possibilities with SHU 450 Echovist. Acta Eur Fertil 1991;22: 2792-82.
191. Vorwerk D, Gehl HB, Schlief R, Nelles A. Gunther RW. Dynamic contrast medium-aided ultrasound cavography in patients with a caval filter. Ultraschall Med 1990;11:146-149.
192. Walday P, Østensen J, Tolleshaug H, Holtz E. Albunex, a new ultrasound contrast agent. Effects on hemodynamics, contrast and hemodistribution in different species. Invest Radiol 1994;29:5142-144.
193. Widder DJ, Simeone JF. Microbubbles as a contrast agent for neurosonography and ultrasound-guided catheter manipulation: in vitro studies. Am J Roentgen 1986;147:347-352.
194. Wiencek JG, Feinstein SB, Walker R, Aronson S. Pitfalls in quantitative contrast echocardiography: the steps to quantification of perfusion. J Am Soc Echocardio 1993;6:395-416.
195. Williams AR, Kobowics G, Cramer E, Schlief R. The effects of the microbubble suspension SHU454 (Echovist®) on ultrasound-induced cell lesions in the rotating tube exposure system. Echocardiography 1991;8:423-433.
196. Winkelmann JW, Kenner MD, Dave R, Chandwaney RH, Feinstein SB. Contrast echocardiography. Ultrasound Med Biol 1994;20: 507-515.
197. Wolman I, Hartoov J, Amster R, Gal I, David MP, Jaffa AJ. Transvaginal sonohysterography for the early detection of residual trophoblastic tissue. Ultrasound Obstet Gynecol 1996; 8(Suppl. 1):37.
198. Wu CC, Lee CN, Chen TM, Shyu MK, Hsieh CY, Chen HY, Hsieh FJ. Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 1994;73:1251-1256.
199. Yarali H, Gurgan T, Erden A, Kishisci H. Color Doppler hysterosalpingo-sonography: A single and potentially useful method to evaluate fallopian tubal patency. Hum Reprod 1994;9:64-66.
200. Yasuhara K, Kimura K, Ohto M, Matsutani S, Ebara M, Tsuchiya Y, Saisho H. Pulsed Doppler in the diagnosis of small liver tumours. Br J Radiol 1988;61:898-902.
201. Ziskin MC, Bonakdarpour A, Weinstein DP, Lynch PR. Contrast agents for diagnostic ultrasound. Invest Radiol 1972;7: 500-505.
202. Zotz RJ, Genth S, Mitrovic V, Waaler A, Erbel R, Meyer J. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure. Eur Heart J 1996;17: 302-307.